BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16389184)

  • 1. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis.
    Will O; Purkayastha S; Chan C; Athanasiou T; Darzi AW; Gedroyc W; Tekkis PP
    Lancet Oncol; 2006 Jan; 7(1):52-60. PubMed ID: 16389184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of USPIO-enhanced MRI for lymph-node metastases in different body regions: a meta-analysis.
    Wu L; Cao Y; Liao C; Huang J; Gao F
    Eur J Radiol; 2011 Nov; 80(2):582-9. PubMed ID: 20047813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
    Tatsumi Y; Tanigawa N; Nishimura H; Nomura E; Mabuchi H; Matsuki M; Narabayashi I
    Gastric Cancer; 2006; 9(2):120-8. PubMed ID: 16767368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?
    Harisinghani MG; Saksena MA; Hahn PF; King B; Kim J; Torabi MT; Weissleder R
    AJR Am J Roentgenol; 2006 Jan; 186(1):144-8. PubMed ID: 16357394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of lymph node metastases in head and neck cancer: a meta-analysis comparing US, USgFNAC, CT and MR imaging.
    de Bondt RB; Nelemans PJ; Hofman PA; Casselman JW; Kremer B; van Engelshoven JM; Beets-Tan RG
    Eur J Radiol; 2007 Nov; 64(2):266-72. PubMed ID: 17391885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of nanoparticle use in cancer imaging.
    Islam T; Harisinghani MG
    Cancer Biomark; 2009; 5(2):61-7. PubMed ID: 19414922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study.
    Anzai Y; Piccoli CW; Outwater EK; Stanford W; Bluemke DA; Nurenberg P; Saini S; Maravilla KR; Feldman DE; Schmiedl UP; Brunberg JA; Francis IR; Harms SE; Som PM; Tempany CM;
    Radiology; 2003 Sep; 228(3):777-88. PubMed ID: 12954896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide.
    Nishimura H; Tanigawa N; Hiramatsu M; Tatsumi Y; Matsuki M; Narabayashi I
    J Am Coll Surg; 2006 Apr; 202(4):604-11. PubMed ID: 16571430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
    Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
    Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphotropic nanoparticle enhanced MR imaging (LNMRI) technique for lymph node imaging.
    Saksena MA; Saokar A; Harisinghani MG
    Eur J Radiol; 2006 Jun; 58(3):367-74. PubMed ID: 16472955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphotropic nanoparticle-enhanced MRI for independent prediction of lymph node malignancy: a logistic regression model.
    Pandharipande PV; Mora JT; Uppot RN; Goehler A; Braschi M; Halpern EF; Gazelle GS; Harisinghani MG
    AJR Am J Roentgenol; 2009 Sep; 193(3):W230-7. PubMed ID: 19696264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR lymphography using iron oxide particles. Detection of lymph node metastases in the VX2 rabbit tumor model.
    Taupitz M; Wagner S; Hamm B; Dienemann D; Lawaczeck R; Wolf KJ
    Acta Radiol; 1993 Jan; 34(1):10-5. PubMed ID: 8427741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of lymphotropic nanoparticle-enhanced MRI sequences in patients with various primary cancers.
    Saksena M; Harisinghani M; Hahn P; Kim J; Saokar A; King B; Weissleder R
    AJR Am J Roentgenol; 2006 Dec; 187(6):W582-8. PubMed ID: 17114509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Harada T; Tanigawa N; Matsuki M; Nohara T; Narabayashi I
    Eur J Radiol; 2007 Sep; 63(3):401-7. PubMed ID: 17398053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of lymph node metastases assessment with the use of USPIO-enhanced MR imaging at 1.5 T versus 3.0 T in a rabbit model.
    Choi SH; Kim KH; Moon WK; Kim HC; Cha JH; Paik JH; Chang KH
    J Magn Reson Imaging; 2010 Jan; 31(1):134-41. PubMed ID: 20027581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
    Deserno WM; Harisinghani MG; Taupitz M; Jager GJ; Witjes JA; Mulders PF; Hulsbergen van de Kaa CA; Kaufmann D; Barentsz JO
    Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria.
    Tokuhara T; Tanigawa N; Matsuki M; Nomura E; Mabuchi H; Lee SW; Tatsumi Y; Nishimura H; Yoshinaka R; Kurisu Y; Narabayashi I
    Gastric Cancer; 2008; 11(4):194-200. PubMed ID: 19132480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients.
    Barentsz JO; Fütterer JJ; Takahashi S
    Eur J Radiol; 2007 Sep; 63(3):369-72. PubMed ID: 17689215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study.
    Heesakkers RA; Hövels AM; Jager GJ; van den Bosch HC; Witjes JA; Raat HP; Severens JL; Adang EM; van der Kaa CH; Fütterer JJ; Barentsz J
    Lancet Oncol; 2008 Sep; 9(9):850-6. PubMed ID: 18708295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenic imaging with ultrasmall superparamagnetic iron oxide ferumoxtran-10 (AMI-7227): preliminary observations.
    Harisinghani MG; Saini S; Weissleder R; Rubin D; deLange E; Harms S; Weinreb J; Small W; Sukerkar A; Brown JJ; Zelch J; Lucas M; Morris M; Hahn PF
    J Comput Assist Tomogr; 2001; 25(5):770-6. PubMed ID: 11584239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.